Espa?ol
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
Call us at 1-800-227-2345
Available any time of day or night
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Your thyroid gland absorbs nearly all the iodine that enters your body. Because of this, radioactive iodine (RAI, also called iodine-131 or I-131) can be used to treat some types of thyroid cancer.
During this treatment, radioactive iodine is put into your body by taking a pill, drinking a liquid, or getting a shot in your vein.
When RAI is put into the body, it collects mainly in thyroid cells. The radiation from this treatment can destroy the thyroid gland and any other thyroid cells that take up iodine (including cancer cells). Because most of the RAI collects in thyroid cells, the radiation has less effect on the rest of your body.
The radiation dose used in radioactive iodine therapy is much stronger than the doses used in radioiodine scans, which are described in .
RAI can be used to treat some differentiated (papillary or follicular) thyroid cancers. It can be used to:
RAI can often help treat papillary or follicular thyroid cancer that has spread to the neck or other parts of the body. But the benefits of RAI are less clear for people with small cancers of the thyroid gland that do not seem to have spread, which can often be removed completely with .
Radioactive iodine therapy isn’t used to treat anaplastic (undifferentiated) or medullary thyroid cancers because these types of cancer do not take up iodine.
For RAI therapy to be most effective, you need to have a high level of thyroid-stimulating hormone (TSH or thyrotropin) in your blood. This hormone makes thyroid cells (including cancer cells) take up radioactive iodine.
If your thyroid has been removed, there are 2 ways to raise your TSH levels before being treated with RAI.
Most doctors also recommend that you follow a low-iodine diet for 1 or 2 weeks before treatment. This typically means limiting or avoiding foods that contain iodized salt and red dye #3, as well as dairy products, eggs, seafood, and soy.
RAI is usually given in a special radiology department called nuclear medicine, either at an outpatient clinic or in the hospital. It can be taken by mouth as a pill or liquid, or it can be injected into a vein. You might also be given medicine to prevent nausea. Usually, only one treatment is needed. A small number of people may need a second treatment.
Your body will give off low levels of radiation for some time after you get RAI therapy. You might need to be in the hospital for a few days after treatment, staying in a special isolation room to prevent others from being exposed to radiation. This will depend on the dose you’re given and where you get your treatment.
Once you are allowed to go home, you will be told how to protect others from radiation exposure and how long you need to take these precautions. Be sure you understand the instructions before you leave the hospital or clinic.
If you go home the same day as your treatment: You should not use public transportation (taxis, rideshares, buses, or trains). If possible, drive yourself. If this isn’t possible, try to sit as far away from the driver as possible. Do not have anyone who is pregnant or trying to get pregnant drive you home.
Levels of radiation in your urine: I-131 leaves the body through your urine, so you will likely be told to drink lots of fluids for the first few days after treatment, and to wipe down any surfaces the urine touches.
Here are some questions you may want to ask your care team before going home.
You'll also want to find out when it is safe for you to:
To learn more, see Radiation Therapy Safety.
Short-term side effects of RAI treatment may include:
Chewing gum or sucking on hard candy may help with dry mouth and other salivary gland problems.
Problems with tears: Radioiodine treatment can affect the amount of tears some people make. Some people might notice dry eyes, while others might have excessive tears. If you wear contact lenses, ask your doctor how long you should keep them out.
Fertility issues for men: Men who receive large total doses of radiation because of many treatments with RAI may have lower sperm counts or, rarely, become infertile.
Fertility issues for women: Radioactive iodine may affect a woman’s ovaries, and some women may have irregular periods for up to a year after treatment. Although no ill effects have been noted in children born to parents who received RAI, many doctors recommend women avoid becoming pregnant for at least 6 months after treatment.
Second cancers: People who have had RAI therapy may have a slightly increased risk of developing some types of cancer in the future. This includes leukemia, stomach cancer, and salivary gland cancer. Doctors aren’t sure exactly how much this risk is increased, but most large studies have found that this is a very rare complication.
Talk to your health care team if you have any questions about the possible risks and benefits of your treatment.
The American Cancer Society medical and editorial content team
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as editors and translators with extensive experience in medical writing.
Asban A, Patel AJ, Reddy S, Wang T, Balentine CJ, Chen H. Chapter 68: Cancer of the Endocrine System. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 6th ed. Philadelphia, Pa. Elsevier: 2020.
American Thyroid Association Guidelines Task Force, Kloos RT, Eng C, Evans DB, et al. Medullary thyroid cancer: Management guidelines of the American Thyroid Association. Thyroid. 2015 25;19:567-610.
American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2016; 26:1-133.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Thyroid Carcinoma. V.2.2024. Accessed at https://www.nccn.org/professionals/physician_gls/pdf/thyroid.pdf on April 15, 2024.
Tuttle RM. Differentiated thyroid cancer: Radioiodine treatment. UpToDate. 2024. Accessed at https://www.uptodate.com/contents/differentiated-thyroid-cancer-radioiodine-treatment on April 8, 2024.
Last Revised: August 23, 2024
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.
If this was helpful, donate to help fund patient support services, research, and cancer content updates.